Posts
| ||
| Fat Chance: Europe May Nix Vivus Diet Pill // Pharmalot By Ed Silverman Just two months after Vivus finally won FDA approval for its Qsymia prescription diet pill, the drugmaker late last week disclosed that European regulators are not inclined to issue the same recommendation. Not surprisingly, Vivus stock dove ... Pharmalot |
This as-it-happens Google Alert is brought to you by Google.
Delete this alert.
Create another alert.
Manage your alerts.
No comments:
Post a Comment